Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

Sankar Jagadeeshan; Ganesh Venkatraman; Suresh K. Rayala

doi:10.1080/14728222.2016.1239719

Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

Sankar Jagadeeshan, Ganesh Venkatraman, Suresh K. Rayala

Research output: Contribution to journal › Editorial

6 Scopus citations

Original language	English
Pages (from-to)	1283-1285
Number of pages	3
Journal	Expert Opinion on Therapeutic Targets
Volume	20
Issue number	11
DOIs	https://doi.org/10.1080/14728222.2016.1239719
State	Published - 1 Nov 2016
Externally published	Yes

Keywords

Pak1
Pak1 inhibitors
gemcitabine resistance
pancreatic adenocarcinoma

ASJC Scopus subject areas

Molecular Medicine
Pharmacology
Drug Discovery
Clinical Biochemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/14728222.2016.1239719

Cite this

@article{e64b049298c8448095f37d62f440762c,

title = "Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer",

keywords = "Pak1, Pak1 inhibitors, gemcitabine resistance, pancreatic adenocarcinoma",

author = "Sankar Jagadeeshan and Ganesh Venkatraman and Rayala, {Suresh K.}",

year = "2016",

month = nov,

day = "1",

doi = "10.1080/14728222.2016.1239719",

language = "English",

volume = "20",

pages = "1283--1285",

journal = "Expert Opinion on Therapeutic Targets",

issn = "1472-8222",

publisher = "Taylor and Francis Ltd.",

number = "11",

}

TY - JOUR

T1 - Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

AU - Jagadeeshan, Sankar

AU - Venkatraman, Ganesh

AU - Rayala, Suresh K.

PY - 2016/11/1

Y1 - 2016/11/1

KW - Pak1

KW - Pak1 inhibitors

KW - gemcitabine resistance

KW - pancreatic adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=84989271445&partnerID=8YFLogxK

U2 - 10.1080/14728222.2016.1239719

DO - 10.1080/14728222.2016.1239719

M3 - Editorial

C2 - 27654702

AN - SCOPUS:84989271445

SN - 1472-8222

VL - 20

SP - 1283

EP - 1285

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

IS - 11

ER -

Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this